Correlation Between Edgewise Therapeutics and MannKind Corp

Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and MannKind Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and MannKind Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edgewise Therapeutics and MannKind Corp, you can compare the effects of market volatilities on Edgewise Therapeutics and MannKind Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of MannKind Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and MannKind Corp.

Diversification Opportunities for Edgewise Therapeutics and MannKind Corp

0.76

Correlation Coefficient

Edgewise Therapeutics  MannKind Corp

Poor diversification

The 3 months correlation between Edgewise and MannKind is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and MannKind Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MannKind Corp and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with MannKind Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MannKind Corp has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and MannKind Corp go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and MannKind Corp

Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 4.56 times more return on investment than MannKind Corp. However, Edgewise Therapeutics is 4.56 times more volatile than MannKind Corp. It trades about 0.15 of its potential returns per unit of risk. MannKind Corp is currently generating about 0.11 per unit of risk. If you would invest  1,788  in Edgewise Therapeutics on August 31, 2024 and sell it today you would earn a total of  1,432  from holding Edgewise Therapeutics or generate 80.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Edgewise Therapeutics  vs.  MannKind Corp

Edgewise Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

MannKind Corp

Risk-Adjusted Performance

8 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady forward-looking signals, MannKind Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Edgewise Therapeutics and MannKind Corp

The main advantage of trading using opposite Edgewise Therapeutics and MannKind Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, MannKind Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MannKind Corp will offset losses from the drop in MannKind Corp's long position.

The idea behind Edgewise Therapeutics and MannKind Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.